Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abraham Varghese

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre|June 8, 2004
Hodgkin's disease: Kuwait experienceSalem H Al-Shemmari, Salah Al-Humood, Reem Ameen, et al.
Journal of Clinical and Diagnostic Research : JCDR|May 3, 2016
Rare Hernias Presenting as Acute Abdomen- A Case SeriesRoney Johnson John, Sansho Elavumkal Ulahannan, John S Kurien, et al.
Scandinavian Journal of Gastroenterology|April 12, 2015
B-vitamin status in relation to bone mineral density in treated celiac disease patientsMichelle Clarke, Mary Ward, William Dickey, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 26, 2021
Development and validation of the CoV19-OM intensive care unit score: An early ICU identification for laboratory-confirmed SARS-CoV-2 patients from a retrospective cohort study in OmanEduardo M Lacap, Abraham Varghese, Faryal Khamis, et al.
Scientific Reports|June 8, 2021
SEAMHCRD deterministic compartmental model based on clinical stages of infection for COVID-19 pandemic in Sultanate of OmanAbraham Varghese, Shajidmon Kolamban, Vinu Sherimon, et al.
Blood|October 5, 2016
Minimal residual disease is an independent predictor for 10-year survival in CLLMarwan Kwok, Andy C Rawstron, Abraham Varghese, et al.
Health Technology Assessment (Winchester, England)|June 20, 2017
Clinical effectiveness and cost-effectiveness results from the randomised, Phase IIB trial in previously untreated patients with chronic lymphocytic leukaemia to compare fludarabine, cyclophosphamide and rituximab with fludarabine, cyclophosphamide, mitoxantrone and low-dose rituximab: the Attenuated dose Rituximab with ChemoTherapy In Chronic lymphocytic leukaemia (ARCTIC) trialDena R Howard, Talha Munir, Lucy McParland, et al.
British Journal of Haematology|November 12, 2025
COVID-19-related mortality in a real-world cohort of 18 883 patients with premalignant and malignant haematological neoplasms: An analysis from the UK's Haematological Malignancy Research NetworkAlexandra Smith, Clare Frobisher, Abraham Varghese, et al.
Blood|December 24, 2023
Treatment outcomes of complement protein C5 inhibition in 509 UK patients with paroxysmal nocturnal hemoglobinuriaRichard J Kelly, Matthew Holt, Jennifer Vidler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2014
Rituximab plus chlorambucil as first-line treatment for chronic lymphocytic leukemia: Final analysis of an open-label phase II studyPeter Hillmen, John G Gribben, George A Follows, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre|June 8, 2004
Hodgkin's disease: Kuwait experienceSalem H Al-Shemmari, Salah Al-Humood, Reem Ameen, et al.
Journal of Clinical and Diagnostic Research : JCDR|May 3, 2016
Rare Hernias Presenting as Acute Abdomen- A Case SeriesRoney Johnson John, Sansho Elavumkal Ulahannan, John S Kurien, et al.
Scandinavian Journal of Gastroenterology|April 12, 2015
B-vitamin status in relation to bone mineral density in treated celiac disease patientsMichelle Clarke, Mary Ward, William Dickey, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 26, 2021
Development and validation of the CoV19-OM intensive care unit score: An early ICU identification for laboratory-confirmed SARS-CoV-2 patients from a retrospective cohort study in OmanEduardo M Lacap, Abraham Varghese, Faryal Khamis, et al.
Scientific Reports|June 8, 2021
SEAMHCRD deterministic compartmental model based on clinical stages of infection for COVID-19 pandemic in Sultanate of OmanAbraham Varghese, Shajidmon Kolamban, Vinu Sherimon, et al.
Blood|October 5, 2016
Minimal residual disease is an independent predictor for 10-year survival in CLLMarwan Kwok, Andy C Rawstron, Abraham Varghese, et al.
Health Technology Assessment (Winchester, England)|June 20, 2017
Clinical effectiveness and cost-effectiveness results from the randomised, Phase IIB trial in previously untreated patients with chronic lymphocytic leukaemia to compare fludarabine, cyclophosphamide and rituximab with fludarabine, cyclophosphamide, mitoxantrone and low-dose rituximab: the Attenuated dose Rituximab with ChemoTherapy In Chronic lymphocytic leukaemia (ARCTIC) trialDena R Howard, Talha Munir, Lucy McParland, et al.
British Journal of Haematology|November 12, 2025
COVID-19-related mortality in a real-world cohort of 18 883 patients with premalignant and malignant haematological neoplasms: An analysis from the UK's Haematological Malignancy Research NetworkAlexandra Smith, Clare Frobisher, Abraham Varghese, et al.
Blood|December 24, 2023
Treatment outcomes of complement protein C5 inhibition in 509 UK patients with paroxysmal nocturnal hemoglobinuriaRichard J Kelly, Matthew Holt, Jennifer Vidler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2014
Rituximab plus chlorambucil as first-line treatment for chronic lymphocytic leukemia: Final analysis of an open-label phase II studyPeter Hillmen, John G Gribben, George A Follows, et al.
Pageof 3